Volume 13, Number 1—January 2007
Human Bocavirus in Febrile Children, the Netherlands
To the Editor: Human bocavirus (HBoV) is a recently discovered virus of the family Parvoviridae, genus Bocavirus, which appears to cause widespread respiratory tract infections (RTI) in children. In selected groups of children with RTI, detection rates have varied from 2.8% to 11.3% (1–9). However, the exact prevalence and pathogenic effects of this virus remain to be established.
During a prospective cohort study to evaluate the prognosis of fever at a general practice after-hours service in Rotterdam, nasopharyngeal swabs were collected from febrile children and tested for respiratory viruses, including HBoV. We report the incidence and clinical features of HBoV infection in these children.
From June 1, 2005, through January 16, 2006, all children 3 months to 6 years of age whose parents contacted the after-hours service because of fever, as reported by parents and not further defined, were eligible for inclusion in the study. Children were excluded when the parents could not communicate in Dutch (n = 77) and if the child had already been included within the past 2 weeks (n = 11). A research nurse visited the child at home within 24 hours of inclusion. The child was physically examined, and a nasopharyngeal swab and a blood sample for C-reactive protein measurement were collected. The parents subsequently recorded the child's symptoms in a diary for 7 days. The Central Committee on Research Involving Human Subjects, the Netherlands, approved this study.
Nucleic acids were isolated on a MagnaPure isolation station (Roche Applied Science, Penzberg, Germany) and subsequently analyzed by real-time assays. Detection of HBoV was performed by using a primers set and a fluorescein amadite–labeled TaqMan probe directed against sequences of the NP1 gene. (Sequences are available from the corresponding author.) Testing was routinely done for the following viruses: influenza virus types A and B, parainfluenza virus types 1–4, respiratory syncytial virus (RSV) types A and B, adenovirus, coronavirus (OC43, 229E, and NL63), and rhinovirus.
Nasopharyngeal swabs were collected from 257 (81%) of 319 enrolled children. The overall virus detection rate was 52.9%; most frequently detected were adenovirus (11%), RSV-A (10.5%), parainfluenza virus type 1 (8.5%), and rhinovirus (8%). Five children were included twice; none of them was HBoV positive. The PCR for HBoV was positive in 4 children (1.6%), all boys. The characteristics of these children are shown in the Table.
All 4 children reported rhinorrhea and cough. Patient 1 reported abdominal pain, diarrhea (more than twice daily, with mucus), dyspnea, and a skin rash, along with respiratory symptoms. All symptoms lasted for >1 week. At physical examination, the children were given a score by research nurses on whether they did not appear ill or appeared slightly ill based on standard criteria. Patient 1 had a skin rash and palpable cervical lymph nodes. Patient 4 had palpable lymph nodes and red tonsils.
Patient 1 was given amoxicillin for otitis media, and patient 4 received amoxicillin for tonsillitis, as diagnosed by the general practitioner on the basis of the patient's clinical symptoms, without bacteriologic confirmation. During a 1-week follow-up period, none of the patients sought further medical advice.
Our finding that HBoV may cause RTI is in accordance with the literature (1–6). Our findings support those of others in suggesting a role for HBoV in systemic infection, causing gastrointestinal symptoms and skin rash (6,8).
Our detection rate, in general practice, is lower than the rates reported from former studies of children with RTI (3%–10%) (1–8). Coinfection of HBoV and other viruses was found among 3 (75%) of 4 children (Table). In other studies, coinfection was found in 17.6%–55.6% (mainly adenovirus, RSV, and human metapneumovirus) (1,2,5,7–9). The other detected viruses could have caused the symptoms of patients 2–4. However, HBoV was the only detected virus in 1 child with respiratory symptoms, gastrointestinal symptoms, and rash, and therefore might be the pathogen. Considering the high amount of HBoV in patient 3, symptoms were likely caused by HBoV in this patient as well.
Our ability to analyze severity of disease in our study population was limited because all children had mild disease, and no child was hospitalized. However, all children reported a prolonged course of fever, >7 days or recurrent within 1 week. This finding is in contrast with the mean duration of fever of 2.6 days in the study of Arnold et al., which was based in a hospital setting (6). In our study, none of the HBoV-positive children received a diagnosis of bronchiolitis, pneumonia, or bronchitis, as in previous studies. None of the 4 children in our study was born preterm, compared with 19%–44% of HBoV-positive children in previous studies (5,6). None had a positive history for asthma or other underlying diseases, as did up to 50% of the children in previous studies (1,6).
In conclusion, HBoV was detected in nasopharyngeal swabs of 4 (1.6%) of 257 children <6 years of age who parents contacted a general practice after-hours service. Our results suggest that HBoV might cause mild disease with respiratory and gastrointestinal symptoms and skin rash. Further research, not restricted to susceptible or hospitalized patients, is needed to clarify the prevalence and pathogenicity of this new virus in the general population.
We thank Ann Vossen for the analysis of the swabs.
This study was supported by the Dutch Organization for Health Research and Development (ZonMw), Program Common Diseases.
- Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. MedlineCloning of a human parvovirus by molecular screening of respiratory tract samples.Proc Natl Acad Sci U S A. 2005;102:12891–6.
- Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. MedlineEvidence of human coronavirus HKU1 and human bocavirus in Australian children.J Clin Virol. 2006;35:99–102.
- Ma X, Endo R, Ishiguro N, Ebihara T, Ishiko H, Ariga T, MedlineDetection of human bocavirus in Japanese children with lower respiratory tract infections.J Clin Microbiol. 2006;44:1132–4.
- Bastien N, Brandt K, Dust K, Ward D, Li Y. MedlineHuman Bocavirus infection, Canada.Emerg Infect Dis. 2006;12:848–50.
- Foulongne V, Rodiere M, Segondy M. MedlineHuman Bocavirus in children.Emerg Infect Dis. 2006;12:862–3.
- Arnold JC, Singh KK, Spector SA, Sawyer MH. MedlineHuman bocavirus: prevalence and clinical spectrum at a children's hospital.Clin Infect Dis. 2006;43:283–8.
- Weissbrich B, Neske F, Schubert J, Tollmann F, Blath K, Blessing K, MedlineFrequent detection of bocavirus DNA in German children with respiratory tract infections.BMC Infect Dis. 2006;6:109.
- Chung JY, Han TH, Kim CK, Kim SW. MedlineBocavirus infection in hospitalized children, South Korea.Emerg Infect Dis. 2006;12:1254–6.
- Choi EH, Lee HJ, Kim SJ, Eun BW, Kim NH, Lee JA, MedlineThe association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000–2005.Clin Infect Dis. 2006;43:585–92.
Suggested citation for this article: Monteny M, Niesters HGM, Moll HA, Berger MY. Human bocavirus in febrile children, the Netherlands [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Jan [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/1/06-0819
- Page created: June 28, 2010
- Page last updated: June 28, 2010
- Page last reviewed: June 28, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)